Began my day at 5:45am with usual 200mg #Pristiq and commenced #Vyvanse 30mg. Oddly reassured by name of pharmaceutical company, #Takeda. Thank you interest in Japanese history for this irrational positive bias.

I followed with my standard breakfast of 1 double shot flat white on BonSoy, muesli with fresh apple and BonSoy, then another double shot flat white on BonSoy.

No notable interaction between #SNRI and stimulant medications so far but slightly bitter taste in my mouth; a quick interweb search tells me this is not uncommon for Vyvanse.

12 years of #Pristiq at 200mg/day will - after recent review and evaluation - be augmented with #Vyvanse from tomorrow, starting at 30mg/day.

Adult diagnoses for ASD (2010) and #ADHD is curious, if not bittersweet … if only for teenage or adolescent diagnosis. If only for early treatment and therapy; the family of origin is what it is and so it was not to be.

Will this new pharmacological scaffolding around my brain be effective? How will it interact with the #SNRI I currently take? Time will tell I guess; I hope to no longer misplace quite so much of it.

My #antidepressant (#desvenlafaxine aka #Pristiq) is a #phenethylamine. That's rare. It shares that skeleton with other big names like #MDMA, #mescaline, and #Sudafed.

It's a #SSNRI, blocks #serotonin reuptake 5-10x more strongly than #norepinephrine, and may increase #dopamine turnover in the prefrontal cortex.

It has some subjective aspects quite reminiscent of #phenethylamines I've tried.

#drugs #pharma #pharmacology #antidepressants